Literature DB >> 17068284

Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque.

Andrew P Levy1, Joanne E Levy, Shiri Kalet-Litman, Rachel Miller-Lotan, Nina S Levy, Roy Asaf, Julia Guetta, Chingwen Yang, K Raman Purushothaman, Valentin Fuster, Pedro R Moreno.   

Abstract

OBJECTIVE: Intraplaque hemorrhage increases the risk of plaque rupture and thrombosis. The release of hemoglobin (Hb) from extravasated erythrocytes at the site of hemorrhage leads to iron deposition, which may increase oxidation and inflammation in the atherosclerotic plaque. The haptoglobin (Hp) protein is critical for protection against Hb-induced injury. Two common alleles exist at the Hp locus and the Hp 2 allele has been associated with increased risk of myocardial infarction. We have demonstrated decreased anti-oxidative and anti-inflammatory activity for the Hp 2 protein. We tested the hypothesis that the Hp 2-2 genotype is associated with increased oxidative and macrophage accumulation in atherosclerotic plaques. METHODS AND
RESULTS: The murine Hp gene is a type 1 Hp allele. We created a murine type 2 Hp allele and targeted its insertion to the Hp locus by homologous recombination. Atherosclerotic plaques from C57Bl/6 ApoE-/- Hp 2-2 mice were associated with increased iron (P=0.008), lipid peroxidation (4-hydroxynonenal and ceroid) and macrophage accumulation (P=0.03) as compared with plaques from C57Bl/6 ApoE-/- Hp 1-1 mice.
CONCLUSIONS: Increased iron, lipid peroxidation and macrophage accumulation in ApoE-/- Hp 2-2 plaques suggests that the Hp genotype plays a critical role in the oxidative and inflammatory response to intraplaque hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068284     DOI: 10.1161/01.ATV.0000251020.24399.a2

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  49 in total

1.  Haptoglobin 2-2 genotype is associated with increased risk of type 2 diabetes mellitus in northern Chinese.

Authors:  Xiaohong Shi; Liang Sun; Li Wang; Feng Jin; Junfeng Sun; Xiaoquan Zhu; Lei Tang; Yanchun Qu; Ze Yang
Journal:  Genet Test Mol Biomarkers       Date:  2012-02-02

2.  Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model.

Authors:  Craig Sturgeon; Jinggang Lan; Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2017-04-19       Impact factor: 5.691

Review 3.  Haptoglobin genotype and its role in diabetic cardiovascular disease.

Authors:  Tina Costacou; Andrew P Levy
Journal:  J Cardiovasc Transl Res       Date:  2012-03-24       Impact factor: 4.132

Review 4.  The genetics of vascular complications in diabetes mellitus.

Authors:  Dan Farbstein; Andrew P Levy
Journal:  Cardiol Clin       Date:  2010-08       Impact factor: 2.213

5.  Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype.

Authors:  Joseph J Boyle; Heather A Harrington; Emma Piper; Kay Elderfield; Jaroslav Stark; Robert C Landis; Dorian O Haskard
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

6.  The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.

Authors:  Shiri Kalet-Litman; Pedro R Moreno; Andrew P Levy
Journal:  Atherosclerosis       Date:  2009-09-06       Impact factor: 5.162

Review 7.  Genetic underpinnings of cerebral edema in acute brain injury: an opportunity for pathway discovery.

Authors:  Elayna Kirsch; Natalia Szejko; Guido J Falcone
Journal:  Neurosci Lett       Date:  2020-05-26       Impact factor: 3.046

Review 8.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

9.  Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice.

Authors:  Roy Asaf; Shany Blum; Ariel Roguin; Shiri Kalet-Litman; Jad Kheir; Avi Frisch; Rachel Miller-Lotan; Andrew P Levy
Journal:  Cardiovasc Diabetol       Date:  2009-06-02       Impact factor: 9.951

10.  Emerging hematological targets and therapy for cardiovascular disease: From bench to bedside.

Authors:  Ana Villegas; Fernando A Gonzalez; Leopoldo Llorente; Santiago Redondo
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.